| Data Set Data Element |
|---|
| Demographics |
|---|
| NHS NUMBER |
| LOCAL PATIENT IDENTIFIER |
| ORGANISATION CODE (CODE OF PROVIDER) |
| CARE SPELL IDENTIFIER |
| PERSON FAMILY NAME |
| PERSON GIVEN NAME |
| PATIENT USUAL ADDRESS (AT DIAGNOSIS) |
| POSTCODE OF USUAL ADDRESS (AT DIAGNOSIS) |
| SEX |
| BIRTH DATE |
| GENERAL MEDICAL PRACTITIONER (SPECIFIED) |
| GENERAL MEDICAL PRACTICE CODE (PATIENT REGISTRATION) |
| ORGANISATION CODE (RESPONSIBLE PCT) |
| PERSON FAMILY NAME (AT BIRTH) |
| ETHNIC CATEGORY |
| Referrals |
|---|
| SOURCE OF REFERRAL FOR CANCER |
| REFERRING ORGANISATION CODE |
| REFERRER CODE |
| CANCER REFERRAL PRIORITY TYPE |
| CANCER REFERRAL DECISION DATE |
| REFERRAL REQUEST RECEIVED DATE |
| CONSULTANT CODE |
| MAIN SPECIALTY CODE |
| DATE FIRST SEEN |
| DELAY REASON REFERRAL TO FIRST SEEN (CANCER OR BREAST SYMPTOMS) |
| DELAY REASON COMMENT (FIRST SEEN) |
| TWO WEEK WAIT CANCER OR SYMPTOMATIC BREAST REFERRAL TYPE |
| CANCER OR SYMPTOMATIC BREAST REFERRAL PATIENT STATUS |
| WAITING TIME ADJUSTMENT (FIRST SEEN) |
| WAITING TIME ADJUSTMENT REASON (FIRST SEEN) |
| SOURCE OF REFERRAL FOR OUT-PATIENTS |
| Imaging |
|---|
| SITE CODE (OF IMAGING) |
| CLINICAL INTERVENTION DATE (CANCER IMAGING) |
| CANCER IMAGING MODALITY |
| ANATOMICAL EXAMINATION SITE |
| INVASIVE LESION SIZE (RADIOLOGICAL DETERMINATION) |
| Diagnosis |
|---|
| DIAGNOSIS DATE (CANCER) |
| PRIMARY DIAGNOSIS (ICD) |
| TUMOUR LATERALITY |
| BASIS OF DIAGNOSIS (CANCER) |
| HISTOLOGY (SNOMED) |
| GRADE OF DIFFERENTIATION (AT DIAGNOSIS) |
| Cancer Care Plan |
|---|
| MULTIDISCIPLINARY TEAM DISCUSSION INDICATOR |
| MULTIDISCIPLINARY TEAM DISCUSSION DATE (CANCER) |
| CARE PLAN AGREED DATE |
| RECURRENCE INDICATOR |
| CANCER CARE PLAN INTENT |
| PLANNED CANCER TREATMENT TYPE |
| TREATMENT TYPE SEQUENCE |
| NO CANCER TREATMENT REASON |
| PERFORMANCE STATUS (ADULT) |
| Staging |
|---|
| T CATEGORY (FINAL PRETREATMENT) |
| STAGING CERTAINTY FACTOR (T CATEGORY) |
| N CATEGORY (FINAL PRETREATMENT) |
| STAGING CERTAINTY FACTOR (N CATEGORY) |
| M CATEGORY (FINAL PRETREATMENT) |
| STAGING CERTAINTY FACTOR (M CATEGORY) |
| TNM CATEGORY (FINAL PRETREATMENT) |
| STAGING CERTAINTY FACTOR (TNM CATEGORY) |
| SITE SPECIFIC STAGING CLASSIFICATION |
| TNM CATEGORY (INTEGRATED) |
| T CATEGORY (INTEGRATED STAGE) |
| N CATEGORY (INTEGRATED STAGE) |
| M CATEGORY (INTEGRATED STAGE) |
| Surgery and Other Procedures |
|---|
| SITE CODE (OF SURGERY) |
| CONSULTANT CODE |
| MAIN SPECIALTY CODE |
| CANCER TREATMENT INTENT |
| DECISION TO TREAT DATE (SURGERY) |
| START DATE (SURGERY HOSPITAL PROVIDER SPELL) |
| PROCEDURE DATE |
| PRIMARY PROCEDURE (OPCS) |
| PROCEDURE (OPCS) |
| DISCHARGE DATE (HOSPITAL PROVIDER SPELL) |
| DISCHARGE DESTINATION (HOSPITAL PROVIDER SPELL) |
| Pathology Details |
|---|
| PATHOLOGY INVESTIGATION TYPE |
| SAMPLE RECEIPT DATE |
| INVESTIGATION RESULT DATE |
| CONSULTANT CODE (PATHOLOGIST) |
| ORGANISATION CODE (OF REPORTING PATHOLOGY) |
| PRIMARY DIAGNOSIS (ICD) |
| TUMOUR LATERALITY |
| INVASIVE LESION SIZE |
| SYNCHRONOUS TUMOUR INDICATOR |
| HISTOLOGY (SNOMED) |
| GRADE OF DIFFERENTIATION |
| CANCER VASCULAR OR LYMPHATIC INVASION |
| EXCISION MARGIN |
| NODES EXAMINED NUMBER |
| NODES POSITIVE NUMBER |
| T CATEGORY (PATHOLOGICAL) |
| N CATEGORY (PATHOLOGICAL) |
| M CATEGORY (PATHOLOGICAL) |
| TNM CATEGORY (PATHOLOGICAL) |
| SERVICE REPORT IDENTIFIER |
| SERVICE REPORT STATUS |
| SPECIMEN NATURE |
| ORGANISATION CODE (REQUESTED BY) |
| CARE PROFESSIONAL CODE (REQUESTED BY) |
| T CATEGORY EXTENDED (PATHOLOGICAL) |
| M CATEGORY EXTENDED (PATHOLOGICAL) |
| Chemotherapy and other drugs |
|---|
| SITE CODE (OF CANCER DRUG TREATMENT) |
| CONSULTANT CODE |
| MAIN SPECIALTY CODE |
| DECISION TO TREAT DATE (ANTI-CANCER DRUG REGIMEN) |
| DRUG THERAPY TYPE |
| DRUG TREATMENT INTENT |
| DRUG REGIMEN ACRONYM |
| START DATE (ANTI-CANCER DRUG REGIMEN) |
| RECORDED HEIGHT (CANCER DRUG TREATMENT) |
| RECORDED WEIGHT (CANCER DRUG TREATMENT) |
| PERSON BODY SURFACE AREA (PRETREATMENT) |
| CREATININE CLEARANCE |
| START DATE (ANTI-CANCER DRUG FRACTION) |
| ANTI-CANCER DRUG CYCLE IDENTIFIER |
| DAY NUMBER (ANTI-CANCER DRUG CYCLE) |
| DURATION OF ANTI-CANCER DRUG CYCLE |
| DRUG PROGRAMME RESPONSE |
| PLANNED TREATMENT CHANGE REASON |
| HEALTHCARE RESOURCE GROUP CODE |
| Radiotherapy (Teletherapy) |
|---|
| SITE CODE (OF TELETHERAPY) |
| CONSULTANT CODE |
| DECISION TO TREAT DATE (TELETHERAPY TREATMENT COURSE) |
| CANCER TREATMENT INTENT |
| START DATE (TELETHERAPY TREATMENT COURSE) |
| END DATE (TELETHERAPY TREATMENT COURSE) |
| RADIOTHERAPY PRESCRIBED DOSE |
| TELETHERAPY PRESCRIBED FRACTIONS |
| RADIOTHERAPY PRESCRIBED DURATION |
| RADIOTHERAPY ACTUAL DOSE |
| TELETHERAPY ACTUAL FRACTIONS |
| DURATION OF TELETHERAPY TREATMENT COURSE |
| TELETHERAPY BEAM TYPE |
| TELETHERAPY BEAM ENERGY |
| TELETHERAPY FIELDS CLASSIFICATION |
| TELETHERAPY COMPLEXITY GROUP |
| RADIOTHERAPY ANAESTHETIC |
| TELETHERAPY MULTIPLE PLANNING |
| HEALTHCARE RESOURCE GROUP CODE |
| TREATMENT COURSE STATUS |
| Radiotherapy (Brachytherapy) |
|---|
| SITE CODE (OF BRACHYTHERAPY) |
| CONSULTANT CODE |
| DECISION TO TREAT DATE (BRACHYTHERAPY TREATMENT COURSE) |
| CANCER TREATMENT INTENT |
| BRACHYTHERAPY TYPE |
| START DATE (BRACHYTHERAPY TREATMENT COURSE) |
| END DATE (BRACHYTHERAPY TREATMENT COURSE) |
| RADIOTHERAPY PRESCRIBED DOSE |
| BRACHYTHERAPY PRESCRIBED FRACTIONS |
| RADIOTHERAPY PRESCRIBED DURATION |
| RADIOTHERAPY ACTUAL DOSE |
| BRACHYTHERAPY DOSE RATE |
| DURATION OF BRACHYTHERAPY TREATMENT COURSE |
| BRACHYTHERAPY ISOTOPE TYPE |
| RADIOTHERAPY ANAESTHETIC |
| UNSEALED SOURCE PATIENT TYPE |
| BRACHYTHERAPY DELIVERY TYPE |
| HEALTHCARE RESOURCE GROUP CODE |
| TREATMENT COURSE STATUS |
| Palliative Care |
|---|
| DECISION TO TREAT DATE (SPECIALIST PALLIATIVE TREATMENT COURSE) |
| START DATE (SPECIALIST PALLIATIVE TREATMENT COURSE) |
| Clinical Trials |
|---|
| PATIENT TRIAL STATUS (CANCER) |
| CANCER CLINICAL TRIAL TREATMENT TYPE |
| Clinical Status Assessment |
|---|
| CLINICAL STATUS ASSESSMENT DATE (CANCER) |
| PRIMARY TUMOUR STATUS |
| NODAL STATUS |
| METASTATIC STATUS |
| MARKER RESPONSE STATUS |
| PERFORMANCE STATUS (ADULT) |
| TREATMENT TYPE (CANCER MORBIDITY) |
| MORBIDITY CODE (CANCER SURGERY) |
| PATIENT FOLLOW-UP STATUS (CANCER) |
| MORBIDITY CODE (CHEMOTHERAPY) |
| MORBIDITY CODE (RADIOTHERAPY) |
| MORBIDITY CODE (COMBINATION) |
| Death Details |
|---|
| PERSON DEATH DATE |
| DEATH LOCATION TYPE |
| DEATH CAUSE IDENTIFICATION METHOD |
| DEATH CAUSE CANCER |
| DEATH CAUSE CODE (IMMEDIATE) |
| DEATH CAUSE CODE (CONDITION) |
| DEATH CAUSE CODE (UNDERLYING) |
| DEATH CAUSE CODE (SIGNIFICANT) |
| DEATH CODE DISCREPANCY ORIGINATOR |
